Sagimet Biosciences Inc. (SGMT) Ownership
SGMT ownership summary
as of October 17, 2026- Institutions
- 77.1% of shares outstanding
- Insiders
- 2.95% of shares outstanding
- Shares outstanding
- 70.3M
- Float
- 56.6M shares available to trade
- Short interest
- 18.32% 11.2M shares short
- Days to cover
- 8.34 short interest up 9.0% vs prior month
- Institutions 77.13%
- Insiders 2.95%
- Other investors 19.91%
SGMT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 20.22% | 6.6M | $52.7M | +5.8M (+722.0%) | June 30, 2026 |
| 2 | Balyasny Asset Management LLC | 11.15% | 3.6M | $29.1M | +3.6M (0.0%) | June 30, 2026 |
| 3 | Woodline Partners LP | 9.23% | 3.0M | $24.1M | +2.0M (+199.8%) | June 30, 2026 |
| 4 | SILVERARC CAPITAL MANAGEMENT, LLC | 9.00% | 2.9M | $23.5M | +2.9M (0.0%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 7.89% | 2.6M | $20.6M | +1.5M (+133.5%) | June 30, 2026 |
| 6 | Bvf Inc | 7.69% | 2.5M | $20.1M | +2.5M (0.0%) | June 30, 2026 |
| 7 | Caligan Partners LP | 7.69% | 2.5M | $20.1M | +2.5M (0.0%) | June 30, 2026 |
| 8 | Affinity Asset Advisors, LLC | 7.68% | 2.5M | $20.0M | +1.6M (+187.8%) | June 30, 2026 |
| 9 | Federated Hermes Inc | 6.42% | 2.1M | $16.7M | +2.1M (+267,085.0%) | June 30, 2026 |
| 10 | Great Point Partners LLC | 6.24% | 2.0M | $16.3M | +2.0M (0.0%) | June 30, 2026 |
| 11 | State Street Corp | 6.13% | 2.0M | $16.0M | +1.9M (+1,449.1%) | June 30, 2026 |
| 12 | Saturn V Capital Management LLC | 4.55% | 1.5M | $11.9M | +1.5M (0.0%) | June 30, 2026 |
| 13 | Geode Capital Management, LLC | 4.44% | 1.4M | $11.6M | +1.1M (+366.5%) | June 30, 2026 |
| 14 | Blue Owl Capital Holdings LP | 3.88% | 1.3M | $10.1M | +926,667 (+277.5%) | June 30, 2026 |
| 15 | Baker Bros Advisors LP | 2.93% | 953K | $7.6M | — | June 30, 2026 |
| 16 | Millennium Management LLC | 2.88% | 937K | $7.5M | +74,722 (+8.7%) | June 30, 2026 |
| 17 | Aberdeen Group PLC | 2.61% | 848K | $6.8M | +847,700 (0.0%) | June 30, 2026 |
| 18 | The Goldman Sachs Group Inc | 2.33% | 759K | $6.1M | +589,827 (+348.5%) | June 30, 2026 |
| 19 | Hillhouse Capital Advisors, Ltd. | 2.23% | 725K | $5.8M | — | June 30, 2026 |
| 20 | Ameriprise Financial Inc | 1.79% | 581K | $4.7M | +581,217 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 18 holders added 34.0M shares and 0 cut 0.
SGMT top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Federated Hermes Kaufmann Small Cap A | 6.41% | 2.1M | $16.7M | +2.1M (0.0%) | June 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 5.72% | 1.9M | $14.9M | — | August 31, 2026 |
| 3 | iShares Russell 2000 ETF | 4.70% | 1.5M | $12.3M | −17,600 (−1.1%) | September 30, 2026 |
| 4 | State Street® SPDR® S&P® Biotech ETF | 3.91% | 1.3M | $10.2M | −24,300 (−1.9%) | September 30, 2026 |
| 5 | abrdn Life Sciences Investors | 3.31% | 1.1M | $8.6M | −68,341 (−6.0%) | August 31, 2026 |
| 6 | BGF World Healthscience A2 | 2.02% | 658K | $5.3M | — | June 30, 2026 |
| 7 | Fidelity Small Cap Index | 1.98% | 643K | $5.2M | +4,861 (+0.8%) | July 31, 2026 |
| 8 | BlackRock Health Sciences Opps Inv A | 1.80% | 585K | $4.7M | — | August 31, 2026 |
| 9 | iShares Biotechnology ETF | 1.38% | 448K | $3.6M | −3,392 (−0.8%) | September 30, 2026 |
| 10 | iShares Russell 2000 Growth ETF | 1.30% | 422K | $3.4M | −534 (−0.1%) | September 30, 2026 |
| 11 | Vanguard Russell 2000 ETF | 1.04% | 338K | $2.7M | +7,668 (+2.3%) | August 31, 2026 |
| 12 | BlackRock Health Sciences Term Trust | 0.93% | 301K | $2.4M | +80,833 (+36.7%) | June 30, 2026 |
| 13 | Fidelity Extended Market Index | 0.88% | 285K | $2.3M | +2,935 (+1.0%) | August 31, 2026 |
| 14 | iShares Micro-Cap ETF | 0.57% | 185K | $1.5M | −1,278 (−0.7%) | September 30, 2026 |
| 15 | Bridgeway Ultra-Small Company | 0.51% | 166K | $1.3M | −78,100 (−31.9%) | June 30, 2026 |
| 16 | Dimensional US Small Cap ETF | 0.45% | 145K | $1.2M | — | September 30, 2026 |
| 17 | Schwab Small Cap Index | 0.44% | 143K | $1.1M | — | August 31, 2026 |
| 18 | iShares Russell 2000 Value ETF | 0.37% | 119K | $956,505 | +180 (+0.2%) | September 30, 2026 |
| 19 | iShares Russell 2000 Small-Cap Idx Instl | 0.34% | 110K | $880,941 | — | August 31, 2026 |
| 20 | Fidelity Total Market Index | 0.32% | 106K | $846,327 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
SGMT insider transactions
latest 6| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-10 | David Happel | Sell | $5.36 | 12,101 | $64,861 |
| 2026-02-10 | Thierry Chauche | Sell | $5.36 | 1,312 | $7,032 |
| 2025-11-20 | George Kemble | Sell | $7.69 | 37,688 | $289,821 |
| 2025-07-21 | David Happel | Sell | $9.13 | 65,478 | $597,814 |
| 2025-07-21 | Eduardo Bruno Martins | Sell | $9.13 | 8,277 | $75,569 |
| 2025-07-21 | Elizabeth Rozek | Sell | $9.13 | 10,780 | $98,421 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
SGMT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns SGMT
Institutional investors own 77.1% of Sagimet Biosciences's shares and insiders 2.95%. The largest holder is BlackRock Inc with 20.22% of the shares (6.6M), as of June 30, 2026. Among the top 20 institutions, 18 added shares and 0 reduced their stake in the latest filings. Short interest is 18.32% of the float, or 8.34 days of average trading volume. The share count rose 46.7% since 2020.
Related: SGMT analyst forecast, SGMT key metrics. See the SGMT stock overview for the latest quote and news.
SGMT ownership FAQ
Who owns the most Sagimet Biosciences stock?
The largest shareholders of Sagimet Biosciences are BlackRock Inc (20.22%), Balyasny Asset Management LLC (11.15%), Woodline Partners LP (9.23%), SILVERARC CAPITAL MANAGEMENT, LLC (9.00%), Vanguard Capital Management, LLC (7.89%).
What percentage of Sagimet Biosciences is owned by institutions?
Institutions hold 77.1% of Sagimet Biosciences's shares outstanding; insiders hold 2.95%.
Which funds own Sagimet Biosciences?
The largest fund holders of Sagimet Biosciences are Federated Hermes Kaufmann Small Cap A (6.41%), Vanguard MStar Total Stk Mkt Idx Invest (5.72%), iShares Russell 2000 ETF (4.70%), State Street® SPDR® S&P® Biotech ETF (3.91%), abrdn Life Sciences Investors (3.31%).
What is Sagimet Biosciences's short interest?
11.2M shares of Sagimet Biosciences were sold short, 18.32% of the float; at the average daily volume it would take 8.34 days to cover.
Are insiders buying or selling Sagimet Biosciences?
Of the latest 6 reported insider transactions in Sagimet Biosciences (since July 21, 2025), 0 were purchases and 6 were sales.
How many shares of Sagimet Biosciences are outstanding?
Sagimet Biosciences has 70.3M shares outstanding, of which 56.6M are in the public float.